Combined Diffusion Imaging and MR Spectroscopy in the Diagnosis of Human Prion Diseases

BACKGROUND AND PURPOSE: The physiopathologic bases underlying the signal intensity changes and reduced diffusibility observed in prion diseases (TSEs) are still poorly understood. We evaluated the interest of MRS combined with DWI both as a diagnostic tool and a way to understand the mechanism underlying signal intensity and ADC changes in this setting. MATERIALS AND METHODS: We designed a prospective study of multimodal MR imaging in patients with suspected TSEs. Forty-five patients with a suspicion of TSE and 11 age-matched healthy volunteers were included. The MR imaging protocol included T1, FLAIR, and DWI sequences. MRS was performed on the cerebellum, pulvinar, right lenticular nucleus, and frontal cortex. MR images were assessed visually, and ADC values were calculated. RESULTS: Among the 45 suspected cases, 31 fulfilled the criteria for probable or definite TSEs (19 sCJDs, 3 iCJDs, 2 vCJDs, and 7 genetic TSEs); and 14 were classified as AltDs. High signals in the cortex and/or basal ganglia were observed in 26/31 patients with TSEs on FLAIR and 29/31 patients on DWI. In the basal ganglia, high DWI signals corresponded to a decreased ADC. Metabolic alterations, increased mIns, and decreased NAA were observed in all patients with TSEs. ADC values and metabolic changes were not correlated; this finding suggests that neuronal stress (vacuolization), neuronal loss, and astrogliosis do not alone explain the decrease of ADC. CONCLUSIONS: MRS combined with other MR imaging is of interest in the diagnosis of TSE and provides useful information for understanding physiopathologic processes underlying prion diseases.

[1]  J. Hauw,et al.  MR spectroscopic pulvinar sign in a case of variant Creutzfeldt-Jakob disease. , 2002, Journal of neuroradiology. Journal de neuroradiologie.

[2]  K. Behar,et al.  Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. , 1998, Magnetic resonance imaging.

[3]  P. Goldman-Rakic,et al.  Proton magnetic resonance spectroscopy in Creutzfeldt‐Jakob disease , 1993, Neurology.

[4]  Peter B Kingsley,et al.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. , 2002, Archives of neurology.

[5]  Y. Itoyama,et al.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease , 2004, Neurology.

[6]  C H Polman,et al.  MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.

[7]  R. Fulbright,et al.  MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study , 2008, American Journal of Neuroradiology.

[8]  Horst Urbach,et al.  MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. , 2005, Brain : a journal of neurology.

[9]  J. Frahm,et al.  On the identification of cerebral metabolites in localized 1H NMR spectra of human brain In vivo , 1991, NMR in biomedicine.

[10]  D. Lanska.  Diagnosis of Creutzfeldt–Jakob disease: Effect of clinical criteria on incidence estimates Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2001, Neurology.

[11]  V. Perry,et al.  MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes , 2007, Neurobiology of Disease.

[12]  K. Kallenberg,et al.  MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study , 2008, European journal of neurology.

[13]  I. Zerr,et al.  MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.

[14]  J. Hauw,et al.  Variant Creutzfeldt–Jakob disease in France and the United Kingdom: Evidence for the same agent strain , 2009, Annals of neurology.

[15]  K. Kallenberg,et al.  Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease , 2008, American Journal of Neuroradiology.

[16]  D. Galanaud,et al.  Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  René M. Botnar,et al.  Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis , 2005, European Radiology.

[18]  R. Poland,et al.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. , 1998, Archives of neurology.

[19]  D. Galanaud,et al.  Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  N. Ayache,et al.  In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. , 2008, Archives of neurology.

[21]  M. Matoba,et al.  Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. , 2001, Journal of computer assisted tomography.

[22]  I. Wilkinson,et al.  Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. , 2003, Clinical radiology.

[23]  C. Duyckaerts,et al.  Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. , 1994, Neuropathology and applied neurobiology.

[24]  N. Venketasubramanian,et al.  Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. , 2004, Magnetic resonance imaging.

[25]  KLAUS-DIETMARMERFSOLDT Jensfrahm.  Localized Proton Spectroscopy Using Stimulated Echoes , 2004 .

[26]  M. Bahn,et al.  Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. , 1999, Archives of neurology.

[27]  T. Yanagihara,et al.  Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease , 2000, Neuroradiology.

[28]  J. Ranjeva,et al.  Metabolic Counterpart of Decreased Apparent Diffusion Coefficient During Hyperacute Ischemic Stroke: A Brain Proton Magnetic Resonance Spectroscopic Imaging Study , 2003, Stroke.

[29]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[30]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[31]  Damien Galanaud,et al.  Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy , 2006, Magnetic resonance in medicine.

[32]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[33]  Didier Dormont,et al.  Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt‐Jakob disease , 2002, Annals of neurology.

[34]  Hiroki Takenaka,et al.  Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. , 2005, AJR. American journal of roentgenology.

[35]  J. Vion-Dury,et al.  A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases , 1993, Journal of Neurological Sciences.

[36]  D. MacManus,et al.  Short TE Quantitative Proton Magnetic Resonance Spectroscopy in Variant Creutzfeldt-Jakob Disease , 2006, European Radiology.

[37]  B. Miller,et al.  Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. , 2005, AJNR. American journal of neuroradiology.

[38]  D. Prayer,et al.  Sequential MRI in a case of Creutzfeldt-Jakob disease , 2002, Neuroradiology.